Now I have enough information to provide a comprehensive answer. Let me compile it.
Here is a thorough, textbook-based overview of what can be used for bloating and abdominal fullness:
Drugs and Measures for Bloating and Abdominal Fullness
Bloating and postprandial fullness (abdominal distension) are core symptoms of functional dyspepsia (postprandial distress syndrome / PDS), gastroparesis, and related GI motility disorders. Treatment is directed at the underlying mechanism.
1. Prokinetic Agents
These accelerate gastric emptying and improve antroduodenal coordination - the most direct treatment for bloating due to delayed gastric emptying.
| Drug | Mechanism | Notes |
|---|
| Metoclopramide | D2 antagonist + 5-HT4 agonist | First-line prokinetic; also antiemetic. Risk of tardive dyskinesia with long-term use |
| Domperidone | Peripheral D2 antagonist | Fewer CNS side-effects than metoclopramide; not available in USA |
| Cisapride | 5-HT4 agonist | Largely withdrawn due to cardiac arrhythmia risk |
| Itopride | D2 antagonist + AChE inhibitor | Available in some countries; dual prokinetic mechanism |
| Acotiamide | M1/M2 antagonist + AChE inhibitor | Approved for functional dyspepsia in Japan and India; enhances acetylcholine release |
| Prucalopride | 5-HT4 agonist | Primarily for constipation, but has some upper GI prokinetic effects |
Prokinetics improve symptoms 40-45% better than placebo in functional dyspepsia, and are particularly effective in the PDS subtype. - Yamada's Textbook of Gastroenterology, 7th ed.
2. Acid-Suppressing Agents
Useful when gastric acid contributes to symptoms (overlap with GERD/peptic disease).
- Proton pump inhibitors (PPIs) - omeprazole, pantoprazole, rabeprazole
- H2-receptor antagonists (H2RAs) - famotidine, ranitidine (note: ranitidine withdrawn in many countries)
H2RAs are only marginally effective for pure functional dyspepsia; PPIs work better when acid is a contributing factor. - Goodman & Gilman's, The Pharmacological Basis of Therapeutics
3. Fundic Relaxing Agents
Target impaired gastric accommodation (the stomach failing to relax properly after meals), causing early satiety and postprandial fullness.
- Buspirone (5-HT1A agonist) - 10 mg TID; improves gastric accommodation, reduces postprandial fullness and bloating. Also anxiolytic.
- Tandospirone - another 5-HT1A agonist with similar effects
- Sumatriptan (5-HT1D agonist) - allows larger volumes before discomfort; mainly used in research settings
- Clonidine (α2 agonist) - reduces gastric sensitivity in some patients
- Glyceryl trinitrate (NO donor) - relaxes gastric fundus; limited clinical use
4. Simethicone and Gas-Reducing Agents
Directly target gas accumulation causing the "bloated" sensation.
- Simethicone (dimethicone) - defoaming agent; breaks up gas bubbles in the GI tract. Available OTC. Combination antacids (e.g., aluminum hydroxide + magnesium hydroxide + simethicone) are widely used.
- Activated charcoal - adsorbs intestinal gas
- Alpha-galactosidase (Beano) - enzyme that breaks down oligosaccharides from beans/vegetables before they ferment; prevents gas production
Simethicone, activated charcoal, and alpha-galactosidase provide benefits for gas and bloating in some patients. - Harrison's Principles of Internal Medicine, 22nd ed.
5. Antacids
For concomitant acid-related symptoms and mild bloating after meals:
- Aluminum hydroxide + magnesium hydroxide combinations
- Calcium carbonate
6. Neuromodulators / Centrally Acting Agents
For refractory cases where visceral hypersensitivity is the driver:
- Tricyclic antidepressants (TCAs) - amitriptyline (start 10-25 mg at bedtime), nortriptyline, imipramine. Blunt visceral pain signaling. Amitriptyline benefits functional dyspepsia, especially epigastric pain syndrome subtype.
- Mirtazapine - particularly helpful for nausea, early satiety, and postprandial fullness in functional dyspepsia
- SSRIs - generally NOT shown to be effective for functional dyspepsia (escitalopram, paroxetine had no benefit in controlled trials)
7. H. pylori Eradication
If H. pylori is detected, eradication can improve dyspeptic symptoms including bloating and fullness in a subset of patients.
8. Herbal / Natural Remedies
- STW-5 (Iberogast) - a mixture of nine herbal agents; has shown efficacy in controlled studies for functional dyspepsia
- Peppermint oil + caraway oil - inhibit gastric smooth muscle contraction; RCTs show symptom improvement in functional dyspepsia
- Probiotics - e.g., Lactobacillus gasseri; may help in some patients
9. Antibiotics (for SIBO-related bloating)
- Rifaximin - non-absorbable antibiotic; one trial suggested benefit in functional dyspepsia; primary use is for small intestinal bacterial overgrowth (SIBO), which can cause significant bloating and fullness
10. Dietary and Lifestyle Measures
- Eating smaller, more frequent meals
- Avoiding gas-producing foods (beans, cruciferous vegetables, carbonated drinks)
- Low-FODMAP diet (for IBS-related bloating)
- Avoiding lying down immediately after meals
Summary Table
| Category | Examples |
|---|
| Prokinetics | Metoclopramide, domperidone, acotiamide, itopride |
| Acid suppressants | PPIs, H2RAs |
| Fundic relaxants | Buspirone, tandospirone |
| Gas reducers | Simethicone, activated charcoal, alpha-galactosidase |
| Antacids | Aluminium/magnesium hydroxide |
| Neuromodulators | Amitriptyline, mirtazapine |
| H. pylori treatment | Eradication triple/quadruple therapy |
| Herbals | Iberogast (STW-5), peppermint + caraway oil |
| Antibiotics | Rifaximin (for SIBO) |
Sources: Yamada's Textbook of Gastroenterology 7th ed., Harrison's Principles of Internal Medicine 22nd ed., Goodman & Gilman's Pharmacological Basis of Therapeutics, Sleisenger & Fordtran's GI and Liver Disease.